3.11
price down icon4.01%   -0.13
after-market After Hours: 3.12 0.01 +0.32%
loading
Codexis Inc stock is traded at $3.11, with a volume of 1.45M. It is down -4.01% in the last 24 hours and up +23.90% over the past month. Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
See More
Previous Close:
$3.24
Open:
$3.23
24h Volume:
1.45M
Relative Volume:
1.76
Market Cap:
$257.65M
Revenue:
$70.14M
Net Income/Loss:
$-76.24M
P/E Ratio:
-2.8018
EPS:
-1.11
Net Cash Flow:
$-57.06M
1W Performance:
+10.28%
1M Performance:
+23.90%
6M Performance:
-36.66%
1Y Performance:
-14.79%
1-Day Range:
Value
$3.01
$3.23
1-Week Range:
Value
$2.81
$3.38
52-Week Range:
Value
$1.90
$6.08

Codexis Inc Stock (CDXS) Company Profile

Name
Name
Codexis Inc
Name
Phone
650-421-8100
Name
Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Name
Employee
188
Name
Twitter
@codexisinc
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
CDXS's Discussions on Twitter

Compare CDXS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CDXS
Codexis Inc
3.11 268.42M 70.14M -76.24M -57.06M -1.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Codexis Inc Stock (CDXS) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-19-24 Downgrade The Benchmark Company Buy → Hold
Jun-03-24 Resumed Jefferies Buy
May-30-24 Initiated Cantor Fitzgerald Overweight
Feb-29-24 Upgrade The Benchmark Company Hold → Buy
Nov-07-23 Downgrade The Benchmark Company Buy → Hold
Aug-07-23 Downgrade TD Cowen Outperform → Market Perform
May-09-23 Downgrade H.C. Wainwright Buy → Neutral
Mar-31-22 Resumed Piper Sandler Overweight
Mar-02-22 Resumed Cowen Outperform
Apr-12-21 Initiated Piper Sandler Overweight
Mar-01-21 Initiated Stifel Buy
Feb-26-21 Reiterated H.C. Wainwright Buy
Mar-10-20 Initiated The Benchmark Company Buy
Jan-17-19 Upgrade First Analysis Sec Neutral → Outperform
May-16-18 Initiated Stephens Overweight
Oct-13-17 Reiterated H.C. Wainwright Buy
May-31-17 Initiated Jefferies Buy
Jan-26-17 Downgrade First Analysis Sec Overweight → Equal-Weight
Jan-04-17 Upgrade Ladenburg Thalmann Neutral → Buy
Jan-06-16 Initiated H.C. Wainwright Buy
View All

Codexis Inc Stock (CDXS) Latest News

pulisher
Jul 25, 2025

What makes Codexis Inc. stock price move sharplyVolume Spike Monitors - Newser

Jul 25, 2025
pulisher
Jul 25, 2025

Codexis Confronts Trade Policy Challenges: Tariffs and Sanctions Threaten Operations - TipRanks

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Codexis Inc. stockRapid growth opportunities - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Is Codexis Inc. a good long term investmentFree Popular Stock Recommendations - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Why Codexis Inc. stock attracts strong analyst attention3x Return Stock Radar - Newser

Jul 24, 2025
pulisher
Jul 24, 2025

How Codexis Inc. stock compares to its top competitorsIs CNFRZ stock undervalued or overvalued nowSignificant capital appreciation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Codexis Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Major Shareholder Makes Bold Move with Codexis Stock Purchase - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Enzymatic Solutions Leader Codexis Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan

Jul 22, 2025
pulisher
Jul 20, 2025

What drives Codexis Inc. stock priceExceptional gains - Autocar Professional

Jul 20, 2025
pulisher
Jul 15, 2025

How Codexis Inc. stock performs during market volatilityFree Market Analysis Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Biocatalysis And Biocatalyst Market Set for Strong Growth Outlook: Codexis, Amano Enzyme, Biocatalysts - newstrail.com

Jul 15, 2025
pulisher
Jul 11, 2025

Codexis, Inc.'s (NASDAQ:CDXS) P/S Is Still On The Mark Following 27% Share Price Bounce - 富途牛牛

Jul 11, 2025
pulisher
Jul 03, 2025

What You Can Learn From Codexis, Inc.'s (NASDAQ:CDXS) P/S - simplywall.st

Jul 03, 2025
pulisher
Jun 27, 2025

With 59% ownership, Codexis, Inc. (NASDAQ:CDXS) boasts of strong institutional backing - Yahoo.co

Jun 27, 2025
pulisher
Jun 24, 2025

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Perspective Therapeutics (CATX) and Codexis (CDXS) - The Globe and Mail

Jun 24, 2025
pulisher
Jun 18, 2025

Synthetic Biology Market Key Players AnalysisBota - openPR.com

Jun 18, 2025
pulisher
Jun 18, 2025

Codexis, Inc. (NASDAQ:CDXS) Position Increased by Assenagon Asset Management S.A. - Defense World

Jun 18, 2025
pulisher
Jun 16, 2025

Opaleye Management Makes a Bold Move with Codexis Stock Purchase! - TipRanks

Jun 16, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Bank of America Corp DE Has $364,000 Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Forecasts Codexis FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Has $253,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 08, 2025

Codexis Inc Stock (CDXS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):